Drug · DIN 02454696
SPC-FENOFIBRATE E
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 7, 2025; first marketed December 14, 2020.
- Drug Identification Number (DIN)
- 02454696
- Company (DIN owner)
- Sun Pharma Canada Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Fenofibrate C10AB05
- Class
- Human
- Record last updated
- August 27, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FENOFIBRATE | 145 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 7, 2025: NOC 36350Supplement to an Abbreviated New Drug Submission (SANDS) · Administrative: Change in product name
- May 28, 2025: NOC 35436Supplement to an Abbreviated New Drug Submission (SANDS) · Change in product name. Update to package labels
- July 16, 2020: NOC 23918Supplement to an Abbreviated New Drug Submission (SANDS) · Change in specifications, Product name change, Revisions to the Product Monograph and inner and outer labels.
- February 26, 2019: NOC 21899Abbreviated New Drug Submission (ANDS) · Manufacturer and prodeuct name change. revisions to the labelling
- May 12, 2016: NOC 18090Abbreviated New Drug Submission (ANDS)